Imaging
in Drug Development
Jeffrey L. Evelhoch,
Ph.D., John R. Griffiths, M.B.B.S., D.Phil., Organizers Monday, 17 May 2004,
11:00 - 13:00 Last
updated 05 May 2009
Course Description: This course will provide an
introduction to the pharmaceutical industry's perspective of the
emerging role for MR and radiologists in drug development, the current
state of the art in MR methods applied in drug development clinical
trials, and the perspective of radiologists participating in those
trials.
Educational Objectives: Upon completion of this session, participants should be able to: Explain
why the pharmaceutical industry is incorporating imaging into the
process of drug development; List at least
two examples of how information provided from MR studies can impact the
development of a drug;
Describe what roles a practicing radiologist should play
in imaging studies associated with clinical trials of new drugs.
Program
Monday,
17 May
Drug
Development in Oncology
11:00
The Role of MR
and Radiologists
Patricia Cole
11:15
Current and
Future MR Methods
Geoff J.M.
Parker
11:30
A Radiologist's
Perspective
Frederick Kelcz
11:45
Panel Discussion
Drug
Development in Osteoarthritis
12:00
The Role of MR
and Radiologists
John C. Waterton
12:15
Current and
Future MR Methods
Garry E. Gold
12:30
Semiquantitative
and Quantitative Imaging Techniques for Drug Discovery and Development
in OA: A Radiologist's Perspective
